Previous studies have shown that fecal microbiota transplantation (FMT) from lean individuals to individuals with obesity and metabolic syndrome transiently reduced peripheral insulin sensitivity, among other metabolic outcomes: total cholesterol (−0.6 mmol/l), HbA1c (−0.2%), and plasma glucose (−0.6 mmol/l) (95). This evidence concerns the gene INS and obesity disorder.